Literature DB >> 9360965

Multiple regulatory elements control transcription of the peripheral myelin protein zero gene.

A M Brown1, G Lemke.   

Abstract

The gene encoding protein zero (P0), the most abundant protein of peripheral nervous system myelin, is expressed uniquely in Schwann cells. Previous studies have demonstrated that much of the cell type specificity of this expression is due to transcriptional control elements in the 1.1-kilobase pair 5'-regulatory region of the gene. We have now analyzed this region and have identified a set of functional elements in the 500 base pairs proximal to the transcription start site. DNA sequence conservation within the 5' regions of the human, mouse, and rat P0 genes correlates closely with the results of promoter deletion analysis of the 1.1-kilobase pair region assayed in Schwann cell cultures and reveals a potent proximal region from position -350 to +45. Sites of protein/DNA interaction within the proximal 500 base pairs of the promoter were identified by footprinting assays. Functional transcriptional elements were identified within the protected regions in the proximal promoter by mutation and transient transfection analysis in P0-expressing cell lines. The core (or basal) P0 promoter is identified as two regulatory elements, a G/C-rich element that binds nuclear factor Sp1 and a CAAT box that binds NF-Y. These core elements are essential for the transcription observed from the transfected promoter in cultured Schwann cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9360965     DOI: 10.1074/jbc.272.46.28939

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Protein zero gene expression is regulated by the glial transcription factor Sox10.

Authors:  R I Peirano; D E Goerich; D Riethmacher; M Wegner
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

2.  Analysis of similarity within 142 pairs of orthologous intergenic regions of Caenorhabditis elegans and Caenorhabditis briggsae.

Authors:  Colleen T Webb; Svetlana A Shabalina; Aleksey Yu Ogurtsov; Alexey S Kondrashov
Journal:  Nucleic Acids Res       Date:  2002-03-01       Impact factor: 16.971

Review 3.  Myelin P0: new knowledge and new roles.

Authors:  Joseph Eichberg
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

Review 4.  N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology.

Authors:  John R Moffett; Brian Ross; Peethambaran Arun; Chikkathur N Madhavarao; Aryan M A Namboodiri
Journal:  Prog Neurobiol       Date:  2007-01-05       Impact factor: 11.685

5.  Regression of schwannomas induced by adeno-associated virus-mediated delivery of caspase-1.

Authors:  Shilpa Prabhakar; Mehran Taherian; Davide Gianni; Thomas J Conlon; Giulia Fulci; Jillian Brockmann; Anat Stemmer-Rachamimov; Miguel Sena-Esteves; Xandra O Breakefield; Gary J Brenner
Journal:  Hum Gene Ther       Date:  2013-01-30       Impact factor: 5.695

6.  Peripheral nerve protein, P0, as a potential receptor for Theiler's murine encephalomyelitis virus.

Authors:  J E Libbey; I J McCright; I Tsunoda; Y Wada; R S Fujinami
Journal:  J Neurovirol       Date:  2001-04       Impact factor: 2.643

7.  Neuropathy-associated Egr2 mutants disrupt cooperative activation of myelin protein zero by Egr2 and Sox10.

Authors:  Scott E LeBlanc; Rebecca M Ward; John Svaren
Journal:  Mol Cell Biol       Date:  2007-02-26       Impact factor: 4.272

8.  Imaging and therapy of experimental schwannomas using HSV amplicon vector-encoding apoptotic protein under Schwann cell promoter.

Authors:  S Prabhakar; G J Brenner; B Sung; S M Messerli; J Mao; M Sena-Esteves; A Stemmer-Rachamimov; B Tannous; X O Breakefield
Journal:  Cancer Gene Ther       Date:  2009-10-16       Impact factor: 5.987

9.  Induction of myelin protein zero by early growth response 2 through upstream and intragenic elements.

Authors:  Sung-Wook Jang; John Svaren
Journal:  J Biol Chem       Date:  2009-06-01       Impact factor: 5.157

10.  A rare myelin protein zero (MPZ) variant alters enhancer activity in vitro and in vivo.

Authors:  Anthony Antonellis; Megan Y Dennis; Grzegorz Burzynski; Jimmy Huynh; Valerie Maduro; Chani J Hodonsky; Mehrdad Khajavi; Kinga Szigeti; Sandeep Mukkamala; Seneca L Bessling; William J Pavan; Andrew S McCallion; James R Lupski; Eric D Green
Journal:  PLoS One       Date:  2010-12-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.